Skip to main content
Contact Us
Subscribe
E-Edition
73°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Guardant Health Inc
(NQ:
GH
)
25.58
-0.35 (-1.35%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Guardant Health Inc
< Previous
1
2
3
4
5
6
7
Next >
Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday
April 22, 2024
Via
Benzinga
Analyst Expectations For Guardant Health's Future
April 05, 2024
Via
Benzinga
Exact Sciences, A Cathie Wood Stock, Surges As Rival Colon Cancer Test Pales
April 02, 2024
The companies are working to detect colon cancer and precancerous markers in blood and/or stool.
Via
Investor's Business Daily
Better Than ChatGPT? New Super AI Bot Says Buy These 3 Stocks.
April 01, 2024
These stocks are solid buys according to the advanced AI model Claude 3, which has been touted as potentially superior to ChatGPT.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday
March 28, 2024
U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corporation (NYSE: REX) rose sharply during Thursday’s session following upbeat...
Via
Benzinga
4 Analysts Have This To Say About Guardant Health
February 23, 2024
Via
Benzinga
Guardant Health: Q4 Earnings Insights
February 22, 2024
Via
Benzinga
Insiders Buying Advance Auto Parts And 2 Other Stocks
March 20, 2024
Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades.
Via
Benzinga
Cancer Test Focused Guardant Health Stock Falls On FDA AdCom Update For Colorectal Test
February 23, 2024
Guardant Health surpasses Q4 2023 revenue expectations, reporting $155.1 million. Precision oncology revenue is up 25% to $142.2 million. Adjusted EPS loss beats consensus. Update on Shield CRC...
Via
Benzinga
Exposures
Product Safety
Decoding 4 Analyst Evaluations For Guardant Health
January 30, 2024
Via
Benzinga
3 Stocks to Buy for the Age of Personalized Medicine
January 28, 2024
Personalized medicine stocks can unlock significant growth from your portfolio. Here are three companies to consider.
Via
InvestorPlace
Bull of the Day - NeoGenomics
January 12, 2024
But in late December, shares took a big hit on patent litigation with competitor Natera. Let's review the primary commercial business of NEO and then that will help put the legal news into context.
Via
Talk Markets
Topics
Intellectual Property
Exposures
Intellectual Property
7 Small-Cap Stocks to Best Position Your Portfolio for a Strong 2024
January 08, 2024
Small cap stocks are anticipated to rise by as much as 50% in 2024 as investors look for growth in new areas of the market.
Via
InvestorPlace
What 7 Analyst Ratings Have To Say About Guardant Health
December 13, 2023
Via
Benzinga
7 Analysts Have This to Say About Guardant Health
November 13, 2023
Via
Benzinga
Earnings Scheduled For November 6, 2023
November 06, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via
Benzinga
4 Cathie Wood Stocks Wall Street Thinks Will Skyrocket 83% to 168% in 2024
January 08, 2024
Even if Wall Street is wrong about these stocks in the new year, Cathie Wood could still be right about them over the long run.
Via
The Motley Fool
Blood-Based Colorectal Cancer CRC Screening Market Likely to Benefit From FDA's Panel Surprise Advisory Possibility: Analyst
December 20, 2023
Tuesday, Guardant Health Inc (NASDAQ: GH) announced that the FDA's Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee is tentatively scheduled to review the premarket...
Via
Benzinga
Exposures
Product Safety
S&P 500, Nasdaq Set For Weaker Open As 'FOMO' Rally Cools: Analyst Says Only 'Black Swan Could Upset Santa's Sleigh' Now
December 20, 2023
Bond yields remain contained, providing a reason for traders to maintain their investments in stocks.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 19, 2023
Via
Benzinga
The Latest Analyst Ratings for Guardant Health
October 20, 2023
Via
Benzinga
Why Guardant Health Stock Popped Again Today
September 28, 2023
Wall Street loves this unprofitable biotech.
Via
The Motley Fool
Jim Cramer: Buy This Financial Stock, 'It's Up Substantially From Where It Was In The Spring'
November 28, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he remains a buyer of SoFi Technologies, Inc. (NASDAQ: SOFI).
Via
Benzinga
Why Is Cancer Blood Test-Focused Guardant Health Stock Trading Lower Today?
November 15, 2023
Guardant Health Inc (NASDAQ: GH) shares are falling after the company announced it intends to appeal its verdict in the U.S.
Via
Benzinga
Cancer Test Firm Guardant Health Posts Smaller Than Expected Q3 Loss, Lifts Annual Sales Outlook
November 07, 2023
Guardant Health Inc (NASDAQ: GH) reported Q3 revenue of $143 million, up 22% Y/Y, beating the consensus of $137.37 million
Via
Benzinga
Bull Of The Day: NeoGenomics
October 24, 2023
NeoGenomics is a small-cap provider of cancer genetics diagnostics. They boast one of the most comprehensive oncology-focused testing menus in the world to help physicians diagnose and treat cancer.
Via
Talk Markets
1 Beaten-Down Healthcare Stock to Buy and Hold For 10 Years
October 11, 2023
This company's fight against a deadly disease could pay off.
Via
The Motley Fool
Which Is the Better Cancer-Testing Healthcare Stock: Exact Sciences or Guardant Health?
October 08, 2023
The oncology diagnostic companies are looking for better solutions in early cancer diagnosis.
Via
The Motley Fool
Why Guardant Health Stock Jumped 15% This Week
September 28, 2023
The precision oncology leader benefited from a pair of positive analyst notes this week. Here's what investors need to know.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
September 28, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.